Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Systematic Review

Published on 16 Sep 2022

Microenvironment immune response induced by tumor ferroptosis—the application of nanomedicine

in Pharmacology of Anti-Cancer Drugs

Tian Yun
Zhenzhu Liu
Jianbo Wang
Rui Wang
Liang Zhu
Zheng Zhu
Xuejian Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1019654

3,353 views
10 citations

Mini Review

Published on 16 Sep 2022

Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview

in Pharmacology of Anti-Cancer Drugs

Xiangwan Miao
Beilei Wang
Kaili Chen
Rui Ding
Jichang Wu
Yi Pan
Peilin Ji
Bin Ye
Mingliang Xiang

Frontiers in Oncology

doi 10.3389/fonc.2022.1008361

4,642 views
16 citations

Perspective

Published on 15 Sep 2022

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?

in Pharmacology of Anti-Cancer Drugs

Alaa Embaby
Lisanne van Merendonk
Neeltje Steeghs
Jos Beijnen
Alwin Huitema

Frontiers in Oncology

doi 10.3389/fonc.2022.940582

2,618 views
2 citations

Original Research

Published on 15 Sep 2022

A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Yimeng Cui
Xin Wang
Lei Zhang
Wei Liu
Jinfeng Ning
Ruixue Gu
Yaowen Cui
Li Cai
Ying Xing

Frontiers in Oncology

doi 10.3389/fonc.2022.974614

4,199 views
8 citations

Review

Published on 15 Sep 2022

Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies

in Pharmacology of Anti-Cancer Drugs

Chitra Thakur
Yiran Qiu
Yao Fu
Zhuoyue Bi
Wenxuan Zhang
Haoyan Ji
Fei Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.971288

12,539 views
38 citations

Original Research

Published on 14 Sep 2022

Icariin attenuates the tumor growth by targeting miR-1-3p/TNKS2/Wnt/β-catenin signaling axis in ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Yanjin Fu
Haiquan Liu
Mengsha Long
Linliang Song
Zuyu Meng
Shaozi Lin
Yiyao Zhang
JiaJia Qin

Frontiers in Oncology

doi 10.3389/fonc.2022.940926

3,423 views
15 citations

Original Research

Published on 14 Sep 2022

The efficacy and safety of 125I brachytherapy combined with pre-operative transarterial chemoembolization in patients with locally advanced head and neck cancer

in Pharmacology of Anti-Cancer Drugs

Menglong Zhang
Jian Zhang
Bijuan Hu
Liyin Huang
Shanjun Song
Haitao Zhu
Chao Chen
Cunkun Chu

Frontiers in Oncology

doi 10.3389/fonc.2022.992399

1,294 views
2 citations

Original Research

Published on 14 Sep 2022

A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Ming-Hua Xie
Zai-Lin Fu
Ai-Lian Hua
Ji-Fang Zhou
Qian Chen
Jian-Bo Li
Shen Yao
Xin-Jun Cai
Min Ge
Li Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.932156

2,364 views
7 citations

Correction

Published on 13 Sep 2022

Corrigendum: The role of NR4A1 in the pathophysiology of osteosarcoma: A comprehensive bioinformatics analysis of the single-cell RNA sequencing dataset

in Pharmacology of Anti-Cancer Drugs

Weidong Liu
Yuedong Hao
Xiao Tian
Jing Jiang
Quanhe Qiu

Frontiers in Oncology

doi 10.3389/fonc.2022.1027056

1,639 views

Editorial

Published on 13 Sep 2022

Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity

in Pharmacology of Anti-Cancer Drugs

Daniel Heudobler
Lina Ghibelli
Albrecht Reichle

Frontiers in Oncology

doi 10.3389/fonc.2022.1005381

924 views
2 citations

Mini Review

Published on 12 Sep 2022

Deconvoluting the complexity of autophagy in colorectal cancer: From crucial pathways to targeted therapies

in Pharmacology of Anti-Cancer Drugs

Liming Qiang
Hongpeng Li
Zhaohui Wang
Lin Wan
Guangfu Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.1007509

2,639 views
3 citations

Brief Research Report

Published on 12 Sep 2022

Further investigation of blockade effects and binding affinities of selected natural compounds to immune checkpoint PD-1/PD-L1

in Pharmacology of Anti-Cancer Drugs

Huifang Li
Navindra P. Seeram
Chang Liu
Hang Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.995461

3,549 views
6 citations

Review

Published on 12 Sep 2022

Targeted and cellular therapies in lymphoma: Mechanisms of escape and innovative strategies

in Pharmacology of Anti-Cancer Drugs

Anagha Deshpande
Javier Munoz

Frontiers in Oncology

doi 10.3389/fonc.2022.948513

6,875 views
9 citations

Case Report

Published on 12 Sep 2022

Case report: ZEB1 expression in three cases of hepatic carcinosarcoma

in Pharmacology of Anti-Cancer Drugs

Mingming Zhang
Dongchang Yang
Lu Li
Lin Liu
Ting Wang
Tao Liu
Lei Li
Yanrong Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.972650

2,316 views
2 citations

Review

Published on 08 Sep 2022

Inhibition and potential treatment of colorectal cancer by natural compounds via various signaling pathways

in Pharmacology of Anti-Cancer Drugs

Mingchuan Wang
Xianjun Liu
Tong Chen
Xianbin Cheng
Huijie Xiao
Xianglong Meng
Yang Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.956793

7,882 views
25 citations

Review

Published on 08 Sep 2022

The recent advances of cancer associated fibroblasts in cancer progression and therapy

in Pharmacology of Anti-Cancer Drugs

Chenxi Wu
Jianmei Gu
Hongbing Gu
XiaoXin Zhang
Xu Zhang
Runbi Ji

Frontiers in Oncology

doi 10.3389/fonc.2022.1008843

6,586 views
11 citations